Literature DB >> 15951423

Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function.

Axel Linke1, Patrick Müller, Daria Nurzynska, Claudia Casarsa, Daniele Torella, Angelo Nascimbene, Clotilde Castaldo, Stefano Cascapera, Michael Böhm, Federico Quaini, Konrad Urbanek, Annarosa Leri, Thomas H Hintze, Jan Kajstura, Piero Anversa.   

Abstract

The purpose of this study was to determine whether the heart in large mammals contains cardiac progenitor cells that regulate organ homeostasis and regenerate dead myocardium after infarction. We report that the dog heart possesses a cardiac stem cell pool characterized by undifferentiated cells that are self-renewing, clonogenic, and multipotent. These clonogenic cells and early committed progeny possess a hepatocyte growth factor (HGF)-c-Met and an insulin-like growth factor 1 (IGF-1)-IGF-1 receptor system that can be activated to induce their migration, proliferation, and survival. Therefore, myocardial infarction was induced in chronically instrumented dogs implanted with sonomicrometric crystals in the region of the left ventricular wall supplied by the occluded left anterior descending coronary artery. After infarction, HGF and IGF-1 were injected intramyocardially to stimulate resident cardiac progenitor cells. This intervention led to the formation of myocytes and coronary vessels within the infarct. Newly generated myocytes expressed nuclear and cytoplasmic proteins specific of cardiomyocytes: MEF2C was detected in the nucleus, whereas alpha-sarcomeric actin, cardiac myosin heavy chain, troponin I, and alpha-actinin were identified in the cytoplasm. Connexin 43 and N-cadherin were also present. Myocardial reconstitution resulted in a marked recovery of contractile performance of the infarcted heart. In conclusion, the activation of resident primitive cells in the damaged dog heart can promote a significant restoration of dead tissue, which is paralleled by a progressive improvement in cardiac function. These results suggest that strategies capable of activating the growth reserve of the myocardium may be important in cardiac repair after ischemic injury.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15951423      PMCID: PMC1157041          DOI: 10.1073/pnas.0502678102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

Review 1.  Myocyte renewal and ventricular remodelling.

Authors:  Piero Anversa; Bernardo Nadal-Ginard
Journal:  Nature       Date:  2002-01-10       Impact factor: 49.962

Review 2.  Prometheus's vulture and the stem-cell promise.

Authors:  Nadia Rosenthal
Journal:  N Engl J Med       Date:  2003-07-17       Impact factor: 91.245

3.  Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy.

Authors:  Konrad Urbanek; Federico Quaini; Giordano Tasca; Daniele Torella; Clotilde Castaldo; Bernardo Nadal-Ginard; Annarosa Leri; Jan Kajstura; Eugenio Quaini; Piero Anversa
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-19       Impact factor: 11.205

4.  Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction.

Authors:  Hidemasa Oh; Steven B Bradfute; Teresa D Gallardo; Teruya Nakamura; Vinciane Gaussin; Yuji Mishina; Jennifer Pocius; Lloyd H Michael; Richard R Behringer; Daniel J Garry; Mark L Entman; Michael D Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-06       Impact factor: 11.205

5.  Adult cardiac stem cells are multipotent and support myocardial regeneration.

Authors:  Antonio P Beltrami; Laura Barlucchi; Daniele Torella; Mathue Baker; Federica Limana; Stefano Chimenti; Hideko Kasahara; Marcello Rota; Ezio Musso; Konrad Urbanek; Annarosa Leri; Jan Kajstura; Bernardo Nadal-Ginard; Piero Anversa
Journal:  Cell       Date:  2003-09-19       Impact factor: 41.582

Review 6.  Stem cells in adult skeletal muscle.

Authors:  Atsushi Asakura
Journal:  Trends Cardiovasc Med       Date:  2003-04       Impact factor: 6.677

7.  Insulin-like growth factor-I is necessary for neural stem cell proliferation and demonstrates distinct actions of epidermal growth factor and fibroblast growth factor-2.

Authors:  Y Arsenijevic; S Weiss; B Schneider; P Aebischer
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

8.  Hepatocyte growth factor/scatter factor is a motogen for interneurons migrating from the ventral to dorsal telencephalon.

Authors:  E M Powell; W M Mars; P Levitt
Journal:  Neuron       Date:  2001-04       Impact factor: 17.173

Review 9.  Clinical applications of stem cells for the heart.

Authors:  Kai C Wollert; Helmut Drexler
Journal:  Circ Res       Date:  2005-02-04       Impact factor: 17.367

10.  Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging.

Authors:  M B Britten; N D Abolmaali; B Assmus; R Lehmann; J Honold; J Schmitt; T J Vogl; H Martin; V Schächinger; S Dimmeler; A M Zeiher
Journal:  Circulation       Date:  2003-10-13       Impact factor: 29.690

View more
  185 in total

1.  Stem cell antigen-1 enhances tumorigenicity by disruption of growth differentiation factor-10 (GDF10)-dependent TGF-beta signaling.

Authors:  Geeta Upadhyay; Yuzhi Yin; Hongyan Yuan; Xin Li; Rik Derynck; Robert I Glazer
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

2.  Adult cardiac-resident MSC-like stem cells with a proepicardial origin.

Authors:  James J H Chong; Vashe Chandrakanthan; Munira Xaymardan; Naisana S Asli; Joan Li; Ishtiaq Ahmed; Corey Heffernan; Mary K Menon; Christopher J Scarlett; Amirsalar Rashidianfar; Christine Biben; Hans Zoellner; Emily K Colvin; John E Pimanda; Andrew V Biankin; Bin Zhou; William T Pu; Owen W J Prall; Richard P Harvey
Journal:  Cell Stem Cell       Date:  2011-12-02       Impact factor: 24.633

3.  Intramuscular VEGF activates an SDF1-dependent progenitor cell cascade and an SDF1-independent muscle paracrine cascade for cardiac repair.

Authors:  David Zisa; Arsalan Shabbir; Michalis Mastri; Tyler Taylor; Ilija Aleksic; Mary McDaniel; Gen Suzuki; Techung Lee
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-30       Impact factor: 4.733

Review 4.  Stem cell therapy for ischemic heart disease.

Authors:  Mohammad Nurulqadr Jameel; Jianyi Zhang
Journal:  Antioxid Redox Signal       Date:  2010-10-28       Impact factor: 8.401

Review 5.  De novo myocardial regeneration: advances and pitfalls.

Authors:  Khawaja Husnain Haider; Stephanie Buccini; Rafeeq P H Ahmed; Muhammad Ashraf
Journal:  Antioxid Redox Signal       Date:  2010-10-12       Impact factor: 8.401

Review 6.  Cardiac stem cell therapy and arrhythmogenicity: prometheus and the arrows of Apollo and Artemis.

Authors:  Alexander R Lyon; Sian E Harding; Nicholas S Peters
Journal:  J Cardiovasc Transl Res       Date:  2008-07-16       Impact factor: 4.132

7.  Stem cell antigen-1 deficiency enhances the chemopreventive effect of peroxisome proliferator-activated receptorγ activation.

Authors:  Hongyan Yuan; Geeta Upadhyay; Yuzhi Yin; Levy Kopelovich; Robert I Glazer
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-28

8.  A proliferative burst during preadolescence establishes the final cardiomyocyte number.

Authors:  Nawazish Naqvi; Ming Li; John W Calvert; Thor Tejada; Jonathan P Lambert; Jianxin Wu; Scott H Kesteven; Sara R Holman; Torahiro Matsuda; Joshua D Lovelock; Wesley W Howard; Siiri E Iismaa; Andrea Y Chan; Brian H Crawford; Mary B Wagner; David I K Martin; David J Lefer; Robert M Graham; Ahsan Husain
Journal:  Cell       Date:  2014-05-08       Impact factor: 41.582

Review 9.  Stem cell paracrine actions and tissue regeneration.

Authors:  Priya R Baraniak; Todd C McDevitt
Journal:  Regen Med       Date:  2010-01       Impact factor: 3.806

10.  Identification and functionality of proteomes secreted by rat cardiac stem cells and neonatal cardiomyocytes.

Authors:  Miroslava Stastna; Isotta Chimenti; Eduardo Marbán; Jennifer E Van Eyk
Journal:  Proteomics       Date:  2010-01       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.